Paula Gratal

Paula Gratal

Auto-generated profile, based on publicly available information

Paula Gratal

Fundación ECO, Madrid, España

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RLRobert D. Little
Robert D. Little
IPIvan Prieto-Potin
Ivan Prieto-Potin
SPSandra Pérez-Baos
Sandra Pérez-Baos
AVAmanda Villalvilla
Amanda Villalvilla
PGPaula Gratal
Paula Gratal
GHGabriel Herrero-Beaumont
Gabriel Herrero-Beaumont
Inflammatory activity in rheumatoid arthritis may alter the regulation of muscle mass leading to a secondary sarcopenia, commonly termed rheumatoid cachexia (RC). We characterized alterations to muscle structure and various pro-inflammatory, catabolic and regenerative markers in an animal model of RC. Antigen induced arthritis (AiA) was performed in 20 male adult rabbits. AiA animals exhibited significantly less weight gain, a markedly elevated serum C-reactive protein (CRP), lighter muscles with shorter cross-sectional diameter and increased myonuclei when compared to controls. Atrogin-1 and MuRF-1 were up-regulated alongside an increase in IL-1β, active NF-κB and a higher ratio of phosphorylated to inactive p38 MAPK. CCL-2 and TNF levels were reduced and IL-6 was unchanged between groups. We observed decreased pSTAT3, unchanged pSTAT1 and Myf5, but increased Pax7, MyoD and myogenin. AiA rabbits had a reduction in myostatin from gastrocnemii and synovium with a congruent decrease in serum myostatin compared to controls. Chronic arthritis induced an RC-like secondary sarcopenia with increased muscle protein breakdown. Elevated IL-1β may trigger proteolysis via elevated NF-κB and p38 MAPK signaling with a compensatory anabolic response suggested by myonuclear expansion, increased Pax7, MyoD and myogenin, reduced pSTAT3 as well as reduced serum, synovial and muscular myostatin.


29 January 2019 in Journal of Inflammation
Verified
Journal Article
Open access
PDF file
SPSandra Pérez-Baos
Sandra Pérez-Baos
PGPaula Gratal
Paula Gratal
JBJuan I. Barrasa
Juan I. Barrasa
ALAna Lamuedra
Ana Lamuedra
OSOlga Sánchez-Pernaute
Olga Sánchez-Pernaute
RLRaquel Largo
Raquel Largo
In order to gain insight into the early effects drawn by JAK inhibitors on intra-joint JAK/STAT-dependent signaling, we sought synovial activation of STATs and their end-products, along with their modification with tofacitinib (TOFA), at flare-up in antigen induced arthritis (AIA). New Zealand rabbits were randomly assigned to four groups –healthy controls, AIA, TOFA-treated AIA, or TOFA-treated controls–. AIA was induced with 4 weekly intra-articular ovalbumin injections in sensitized animals. TOFA (10 mg·kg− 1·day− 1) was administered for the last 2 weeks. Animals were euthanized 24 h after the last injection. AIA animals showed high-grade synovitis, which was partially improved by TOFA. No effects of the treatment were found on serum C-reactive protein or on the synovial macrophage infiltration at this stage. Synovial MMP-1,-3 and -13 expression levels in treated AIA rabbits were found to drop to those of controls, while a downregulation of IL6, IFNγ and TNF was evident in treated versus untreated AIA rabbits. Concurrently, a reduction in pSTAT1 and SOCS1, but not in pSTAT3, SOCS3 or active NFκB-p65, was noted with TOFA. Studying the mechanism of action of immunomodulatory drugs represents a major challenge in vivo, since drug-dependent decreases in inflammation very likely mask direct effects on disease mechanisms. This study design allowed us to prevent any confounding effect resulting from reductions in the overall inflammatory status, hence assessing the true pharmacological actions of TOFA in a very severe synovitis. Our findings point to pSTAT1 and MMPs as early molecular readouts of response to this JAK inhibitor.

11 February 2024 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
JPJavier Puente
Javier Puente
FAFerrán Algaba Arrea
Ferrán Algaba Arrea
ÓRÓscar Buisán Rueda
Óscar Buisán Rueda
DGDaniel Castellano Gauna
Daniel Castellano Gauna
IDIgnacio Durán
Ignacio Durán
VPVicente Guillem Porta
Vicente Guillem Porta

1 April 2018 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
PGP. Gratal
P. Gratal
ALA. Lamuedra
A. Lamuedra
AMAranzazu Mediero
Aranzazu Mediero
GHGabriel Herrero-beaumont
Gabriel Herrero-beaumont
RLRaquel Largo
Raquel Largo

18 May 2018 in IBJ Plus
Verified
Journal Article
Open access
PDF file
SBSandra Pérez Baos
Sandra Pérez Baos
JBJuan Ignacio Barrasa
Juan Ignacio Barrasa
PGPaula Gratal
Paula Gratal
AVAne Larrañaga Vera
Ane Larrañaga Vera
IPIván Prieto Potin
Iván Prieto Potin
RLRaquel Largo
Raquel Largo